Edgewise Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for Edgewise Therapeutics stock have an average target of 39, with a low estimate of 20 and a high estimate of 50. The average target predicts an increase of 25.85% from the current stock price of 30.99.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$20	$39	$45	$50
Change	-35.46%	+25.85%	+45.21%	+61.34%

* Price targets were last updated on Mar 17, 2026.

Analyst Ratings

The average analyst rating for Edgewise Therapeutics stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	1	1	1
Buy	5	5	5	5	5	4
Hold	3	3	3	2	2	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	8	8	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $34 → $45	Buy	Maintains	$34 → $45	+45.21%	Mar 17, 2026
Laura Chico Wedbush	Wedbush	Buy Reiterates $32	Buy	Reiterates	$32	+3.26%	Mar 17, 2026
Cory Kasimov Evercore ISI Group	Evercore ISI Group	Buy Maintains $30 → $45	Buy	Maintains	$30 → $45	+45.21%	Feb 27, 2026
Tessa Romero JP Morgan	JP Morgan	Buy Maintains $33 → $34	Buy	Maintains	$33 → $34	+9.71%	Nov 14, 2025
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $49 → $50	Buy	Maintains	$49 → $50	+61.34%	Nov 7, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

16.26M

EPS This Year

-2.13

from -1.63

EPS Next Year

-2.35

from -2.13

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	-	16.26M
Revenue Growth	-	-	-	-	-	-	-
EPS	-1.14	-1.26	-1.57	-1.45	-1.63	-2.13	-2.35
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	14	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	n/a	53.2M
Avg	n/a	16.3M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2026	2027
High	-1.80	-1.75
Avg	-2.13	-2.35
Low	-2.43	-3.26

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.